|
1
|
World Health Organization (WHO), . A
global brief on hypertension. http://apps.who.int/iris/bitstream/10665/79059/1/WHO_DCO_WHD_2013.2_eng.pdfApril
3–2013
|
|
2
|
Varagic J, Ahmad S, Nagata S and Ferrario
CM: ACE2: Angiotensin II/angiotensin-(1–7) balance in cardiac and
renal injury. Curr Hypertens Rep. 16:4202014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Iwai M and Horiuchi M: Devil and angel in
the renin-angiotensin system: ACE-angiotensin II-AT 1 axis vs.
ACE2-angiotensin-(1–7)-Mas receptor axis. Hypertens Res.
32:533–536. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Samuel P, Ali Q, Sabuhi R, Wu Y and
Hussain T: High Na intake increases renal angiotensin II levels and
reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker
rats. Am J Physiol Renal Physiol. 303:F412–F419. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kobori H, Nangaku M, Navar LG and
Nishiyama A: The intrarenal renin-angiotensin system: From
physiology to the pathobiology of hypertension and kidney disease.
Pharmacol Rev. 59:251–287. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ozkayar N, Dede F, Akyel F, Yildirim T,
Ateş I, Turhan T and Altun B: Relationship between blood pressure
variability and renal activity of the renin-angiotensin system. J
Hum Hypertens. 30:297–302. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nguyen Dinh Cat A and Touyz RM: A new look
at the renin-angiotensin system-focusing on the vascular system.
Peptides. 32:2141–2150. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Velez JC: The importance of the intrarenal
renin-angiotensin system. Nat Clin Pract Nephrol. 5:89–100. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Carey RM: The intrarenal renin-angiotensin
system in hypertension. Adv Chronic Kidney Dis. 22:204–210. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ferrão FM, Lara LS and Lowe J:
Renin-angiotensin system in the kidney: What is new? World J
Nephrol. 3:64–76. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Giani JF, Shah KH, Khan Z, Bernstein EA,
Shen XZ, McDonough AA, Gonzalez-Villalobos RA and Bernstein KE: The
intrarenal generation of angiotensin II is required for
experimental hypertension. Curr Opin Pharmacol. 21:73–81. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Naito Y, Tsujino T, Fujioka Y, Ohyanagi M
and Iwasaki T: Augmented diurnal variations of the cardiac
renin-angiotensin system in hypertensive rats. Hypertension.
40:827–833. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Re RN: The clinical implication of tissue
renin angiotensin systems. Curr Opin Cardiol. 16:317–327. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Paul M, Mehr A Poyan and Kreutz R:
Physiology of local renin-angiotensin systems. Physiol Rev.
86:747–803. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fedoseeva LA, Riazanova MA, Antonov EV,
Dymshits GM and Markel' AL: Renin-angiotensin system gene
expression in the kidney and in the heart in hypertensive ISIAH
rats. Biomed Khim. 57:410–419. 2011.(In Russian). View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pan H, She X, Wu H, Ma J, Ren D and Lu J:
Long-term regulation of the local renin-angiotensin system in the
myocardium of spontaneously hypertensive rats by feeding bioactive
peptides derived from spirulina platensis. J Agric Food Chem.
63:7765–7774. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhong JC, Huang DY, Yang YM, Li YF, Liu
GF, Song XH and Du K: Upregulation of angiotensin-converting enzyme
2 by all-trans retinoic acid in spontaneously hypertensive rats.
Hypertension. 44:907–912. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Malikova E, Galkova K, Vavrinec P,
Vavrincova-Yaghi D, Kmecova Z, Krenek P and Klimas J: Local and
systemic renin-angiotensin system participates in
cardiopulmonary-renal interactions in monocrotaline-induced
pulmonary hypertension in the rat. Mol Cell Biochem. 418:147–157.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu J, Ren DF, Xue YL, Sawano Y, Miyakawa T
and Tanokura M: Isolation of an antihypertensive peptide from
alcalase digest of spirulina platensis. J Agric Food Chem.
58:7166–7171. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lu J, Ren DF, Wang JZ and Tanokura M:
Purification and characterization of an angiotensin I-converting
enzyme inhibitory peptide derived from Spirulina platensis. Prog
Biochem Biophys. 37:568–574. 2010. View Article : Google Scholar
|
|
21
|
Buñag RD: Validation in awake rats of a
tail-cuff method for measuring systolic pressure. J Appl Physiol.
34:279–282. 1973.PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Siragy HM: AT(1) and AT(2) receptors in
the kidney: Role in disease and treatment. Am J Kidney Dis. 36(3
Suppl 1): S4–S9. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Marczak ED, Usui H, Fujita H, Yang Y,
Yokoo M, Lipkowski AW and Yoshikawa M: New antihypertensive
peptides isolated from rapeseed. Peptides. 24:791–798. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Igarashi K, Yoshioka K, Mizutani K,
Miyakoshi M, Murakami T and Akizawa T: Blood pressure-depressing
activity of a peptide derived from silkworm fibroin in
spontaneously hypertensive rats. Biosci Biotechnol Biochem.
70:517–520. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu J, Sawano Y, Miyakawa T, Xue YL, Cai
MY, Egashira Y, Ren DF and Tanokura M: One-week antihypertensive
effect of Ile-Gln-Pro in spontaneously hypertensive rats. J Agric
Food Chem. 59:559–563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu J, Yang Y, Chen L, Ren DF, Cai MY, Wang
JZ, Egashira Y and Tanokura M: In vivo antihypertensive effect of
Val-Glu-Pro in spontaneously hypertensive rats. Prog Biochem
Biophys. 38:353–360. 2011. View Article : Google Scholar
|
|
28
|
Majumder K, Chakrabarti S, Morton JS,
Panahi S, Kaufman S, Davidge ST and Wu J: Egg-derived tri-peptide
IRW exerts antihypert effects in spontaneously hypertensive rats.
PLoS One. 8:e828292013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Bader M and Ganten D: Update on tissue
renin-angiotensin systems. J Mol Med (Berl). 86:615–621. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Carey RM, Jin XH and Siragy HM: Role of
the angiotensin AT2 receptor in blood pressure regulation and
therapeutic implications. Am J Hypertens. 14:98S–102S. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu Z, Yin Y, Zhao W, Chen F and Liu J:
Antihypertensive effect of angiotensin-converting enzyme inhibitory
peptide RVPSL on spontaneously hypertensive rats by regulating gene
expression of the renin-angiotensin system. J Agric Food Chem.
62:912–917. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Červenka L, Bíbová J, Husková Z,
Vaňourková Z, Kramer HJ, Herget J, Jíchová Š, Sadowski J and Hampl
V: Combined suppression of the intrarenal and circulating
vasoconstrictor renin-ACE-ANG II axis and augmentation of the
vasodilator ACE2-ANG 1–7-Mas axis attenuates the systemic
hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
Physiol Res. 64:11–24. 2015.PubMed/NCBI
|
|
33
|
Mizuiri S and Ohashi Y: ACE and ACE2 in
kidney disease. World J Nephrol. 4:74–82. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Soler MJ, Wysocki J and Batlle D: ACE2
alterations in kidney disease. Nephrol Dial Transpl. 28:2687–2697.
2013. View Article : Google Scholar
|
|
35
|
Kuba K, Imai Y and Penninger JM: Multiple
functions of angiotensin-converting enzyme 2 and its relevance in
cardiovascular diseases. Circ J. 77:301–308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
De Mello WC and Frohlich ED: On the local
cardiac renin angiotensin system. Basic and clinical implications.
Peptides. 32:1774–1779. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Patel VB, Clarke N, Wang Z, Fan D,
Parajuli N, Basu R, Putko B, Kassiri Z, Turner AJ and Oudit GY:
Angiotensin II induced proteolytic cleavage of myocardial ACE2 is
mediated by TACE/ADAM-17: A positive feedback mechanism in the RAS.
J Mol Cell Cardiol. 66:167–176. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Patel KP and Schultz HD: Angiotensin
peptides and nitric oxide in cardiovascular disease. Antioxid Redox
Sign. 19:1121–1132. 2013. View Article : Google Scholar
|
|
39
|
Wolf G and Ritz E: Combination therapy
with ACE inhibitors and angiotensin II receptor blockers to halt
progression of chronic renal disease: Pathophysiology and
indications. Kidney Int. 67:799–812. 2005. View Article : Google Scholar : PubMed/NCBI
|
